BackApimeds Pharmaceuticals US Overview

Apimeds Pharmaceuticals US Common Stock

Track Apimeds Pharmaceuticals US's common stock ($1.5K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$1509.00
↓ 98.80% YoYΔ $-124251.00 vs prior year quarter

Peer trimmed avg / median

Loading

Apimeds Pharmaceuticals US Common Stock History

Loading

Apimeds Pharmaceuticals US vs. peers: Common Stock Comparison

Loading

Apimeds Pharmaceuticals US Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Apimeds Pharmaceuticals US (APUS) FAQ

As of the most recent data (June 2026), APUS shows a common stock of $1.5K. That compares with $130K in the prior-year period — down 98.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, APUS's common stock is now $1.5K (was $130K) — a 98.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Apimeds Pharmaceuticals US is outperforming or lagging.

Tracking APUS's common stock over time shows whether Apimeds Pharmaceuticals US is scaling, shrinking, or reshaping that part of the business. The current reading is $1.5K That compares with $130K in the prior-year period — down 98.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Apimeds Pharmaceuticals US's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $1.5K) with ownership activity and broader fundamentals.